Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology|April 21, 2022
Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, AustraliaQingwei Luo, Xue Qin Yu, Clare Kahn, et al.
Asia-Pacific Journal of Clinical Oncology|April 30, 2025
Metastatic Breast Cancer Prevalence in New South Wales, Australia, in 2016: A Health Record Linkage StudyAndrea L Smith, Xue Qin Yu, Dianne L O'Connell, et al.
British Journal of Sports Medicine|November 21, 2023
Effect of exercise interventions on hospital length of stay and admissions during cancer treatment: a systematic review and meta-analysisDavid Mizrahi, Jonathan King Lam Lai, Hayley Wareing, et al.
Plos One|October 22, 2014
Relationship between lifestyle and health factors and severe lower urinary tract symptoms (LUTS) in 106,435 middle-aged and older Australian men: population-based studyDavid P Smith, Marianne F Weber, Kay Soga, et al.
Metabolites|June 26, 2024
Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced ResponseSophie M Pearce, Neil A Cross, David P Smith, et al.
British Journal of Cancer|May 24, 2022
Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective studyVisalini Nair-Shalliker, Albert Bang, Sam Egger, et al.
Plos One|March 9, 2018
Associations between sun sensitive pigmentary genes and serum prostate specific antigen levelsVisalini Nair-Shalliker, Sam Egger, Agata Chrzanowska, et al.
Metabolites|August 26, 2021
Comparison of Osteosarcoma Aggregated Tumour Models with Human Tissue by Multimodal Mass Spectrometry ImagingLucy E Flint, Gregory Hamm, Joseph D Ready, et al.
Scientific Reports|May 10, 2020
Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancerVisalini Nair-Shalliker, Albert Bang, Sam Egger, et al.
HGG Advances|July 9, 2025
Polygenic risk scores for prostate cancer: Comparative evaluations in UK and Australian cohortsHamzeh M Tanha, Matthew H Law, Nathan Ingold, et al.
Pageof 17